Holger Fröhlich

Prof. Dr. Holger Fröhlich holds a Diploma (focus area: Artificial Intelligence) and PhD in Computer Science. After positions as a postdoc at the German Cancer Research Center and as a Senior Scientist at Cellzome AG (now an enterprise of Glaxo-Smith-Kline), he was appointed an associate professorship at the University of Bonn in 2010. In 2015 he joined the global biopharmaceutical company UCB and became the Director of an AI and Data Science research team. Since 12/2019 HF is Head of the AI & Data Science group and Deputy Head of the Department of Bioinformatics at the Fraunhofer Institute for Algorithms and Scientific Computing in Sankt Augustin. In addition, he is teaching as an honorary Professor in the Master programs Life Science Informatics and Computer Science at the University of Bonn.
HF’s focus is on the development of machine learning (ML) algorithms for applications in Precision Medicine, early Drug Discovery and System Medicine, particularly addressing challenges in neurodegenerative disorders. For this purpose, HF has used and developed a broad spectrum of different approaches over the last 20 years. He has developed multiple ML methods for modeling longitudinal patient data, integration of different data modalities, and combination of knowledge with data driven approaches. He is author and co-author of more than 150 publications, and he has been working within a many national and international consortia, such as IDENTIREST (BMBF), AETIONOMY (IMI), RADAR-AD (IMI), The Virtual Brain Cloud (H2020) NFDI4Health (DFG), DIGIPD (ERA Per Med, coordinator), ADIS (JNPD, coordinator) and Real4Reg (Horizon Europe).